home blog news careers français contact

Why so many US oncology drug developers have enhanced their clinical trial performance by leveraging Canada for successful study expansion.

The Reverse Feasibility Program™

A Novel CRO Approach to Site Selection
& Patient Recruitment

Reverse Feasibility Program for 50% faster site start-up.A revolutionary approach to feasibility assessment that accelerates study start-up by matching your protocol with the current study needs of motivated and pre-qualified North American sites.

How it works...

Oncology Clinical Trial News

Scimega's Proven Approach to Site Selection & Patient Recruitment Attracting More Cutting-Edge Oncology Trials to Canada
Scimega Oncology, ( the company behind the revolutionary Reverse Feasibility Program, announced it has been awarded four more cutting-edge oncology clinical trials at 35 centers across Canada, bringing the total to 12 in the last 18-months. Read full release...

Scimega awarded Phase 1b combination study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a novel folate receptor alpha (FRα)-targeting antibody-drug conjugate in combination with Liposomal Doxorubicin, Gemcitabine or Bevacizumab in adults with ovarian cancer and other FOLR1-positive tumors. The trial is active in five centers across Canada.

Scimega awarded Phase 2 randomized, double-blinded, controlled study of a small molecule selective inhibitor of HER2 vs. placebo in combination with Capecitabine and Trastuzumab in patients with pre-treated HER2+ breast carcinoma. The trial is active in 10 centers across Canada.

Scimega awarded Phase 3 study to evaluate the safety and efficacy of a development stage radiopharmaceutical imaging agent to detect clinically significant prostate cancer in men with biopsy proven low-grade prostate cancer who are candidates for active surveillance. The trial is active in 10 centers across Canada.

See all news...

Upcoming Scimega Events

Oncology Clinical Trials East Coast 2016

Jul. 13-14, 2016 in Boston

ASH Annual Meeting

Dec. 3-6, 2016 in San Diego

More details...

Latest Podcast

Role of Patient Input for Oncology Drug Reviews

An interview with Marjorie Morrison, CEO of the Canadian Cancer Action Network

Listen to podcast...

Copyright © Scimega Research Inc. 2014. All rights reserved.
Privacy Policy

Oncology CRO   Clinical Trial Monitoring   Clinical Trial Management   Oncology Community